Report

1 INTRODUCTION 71
1.1 STUDY OBJECTIVES 71
1.2 MARKET DEFINITION 71
1.2.1 INCLUSIONS AND EXCLUSIONS 72
1.3 STUDY SCOPE 73
1.3.1 MARKETS COVERED 73
FIGURE 1 DRUG SCREENING MARKET: MARKETS COVERED 73
1.3.2 REGIONS COVERED 74
FIGURE 2 DRUG SCREENING MARKET: REGIONS COVERED 74
1.3.3 YEARS CONSIDERED 74
1.3.4 CURRENCY CONSIDERED 75
1.4 MARKET STAKEHOLDERS 75
1.5 SUMMARY OF CHANGES 75
1.5.1 RECESSION IMPACT 76
2 RESEARCH METHODOLOGY 77
2.1 RESEARCH DATA 77
FIGURE 3 DRUG SCREENING MARKET: RESEARCH DESIGN 77
2.1.1 SECONDARY DATA 78
2.1.1.1 Key data from secondary sources 79
FIGURE 4 DRUG SCREENING MARKET: KEY DATA FROM SECONDARY SOURCES 79
2.1.2 PRIMARY DATA 79
FIGURE 5 DRUG SCREENING MARKET: PRIMARY SOURCES 80
2.1.2.1 Key data from primary sources 81
FIGURE 6 DRUG SCREENING MARKET: KEY DATA FROM PRIMARY SOURCES 81
2.1.2.2 Key industry insights 81
FIGURE 7 DRUG SCREENING MARKET: KEY INDUSTRY INSIGHTS 81
2.1.2.3 Breakdown of primary interviews 82
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY, DESIGNATION, AND REGION 82
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION 82
2.2 MARKET SIZE ESTIMATION 83
2.2.1 TOTAL MARKET SIZE ESTIMATION 83
2.2.2 REVENUE SHARE ANALYSIS 83
FIGURE 10 MARKET SIZE ESTIMATION (SUPPLY SIDE): REVENUE SHARE ANALYSIS 83
2.2.3 BOTTOM-UP APPROACH 85
FIGURE 11 DRUG SCREENING MARKET: BOTTOM-UP APPROACH 85
2.2.4 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 86
2.2.5 TOP-DOWN APPROACH 86
FIGURE 12 DRUG SCREENING MARKET: TOP-DOWN APPROACH 86
2.3 MARKET GROWTH FORECAST 87
FIGURE 13 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2029) 87
FIGURE 14 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 88
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 89
FIGURE 15 DATA TRIANGULATION METHODOLOGY 89
2.5 STUDY ASSUMPTIONS 90
TABLE 1 DRUG SCREENING MARKET: STUDY ASSUMPTIONS 90
2.6 RISK ASSESSMENT 90
TABLE 2 DRUG SCREENING MARKET: RISK ASSESSMENT 90
2.7 RESEARCH LIMITATIONS 91
2.7.1 METHODOLOGY-RELATED LIMITATIONS 91
2.7.2 SCOPE-RELATED LIMITATIONS 91
2.8 IMPACT OF ECONOMIC RECESSION ON DRUG SCREENING MARKET 91
3 EXECUTIVE SUMMARY 92
FIGURE 16 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION) 92
FIGURE 17 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 93
FIGURE 18 DRUG SCREENING MARKET, BY DRUG TYPE, 2024 VS. 2029 (USD MILLION) 93
FIGURE 19 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2024 VS. 2029 (USD MILLION) 94
FIGURE 20 DRUG SCREENING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 95
FIGURE 21 REGIONAL SEGMENTATION OF DRUG SCREENING MARKET 96
4 PREMIUM INSIGHTS 97
4.1 DRUG SCREENING MARKET OVERVIEW 97
FIGURE 22 GROWING CONSUMPTION OF ILLICIT DRUGS AND ALCOHOL TO DRIVE MARKET 97
4.2 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE AND COUNTRY (2023) 98
FIGURE 23 US AND DRUG SCREENING SERVICES TO COMMAND LARGEST MARKET SHARE DURING FORECAST PERIOD 98
4.3 DRUG SCREENING MARKET: REGIONAL MIX (2022-2029) 98
FIGURE 24 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING STUDY PERIOD 98
4.4 DRUG SCREENING MARKET: GEOGRAPHICAL SNAPSHOT (2024-2029) 99
FIGURE 25 INDIA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD 99
4.5 DRUG SCREENING MARKET: DEVELOPED VS. EMERGING ECONOMIES (2024 VS. 2029) 99
FIGURE 26 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 99
?
5 MARKET OVERVIEW 100
5.1 INTRODUCTION 100
5.2 MARKET DYNAMICS 100
FIGURE 27 DRUG SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 100
5.2.1 DRIVERS 101
5.2.1.1 Growing consumption of illicit drugs and alcohol 101
5.2.1.2 Enforcement of stringent laws mandating drug and alcohol testing 101
5.2.1.3 Increasing number of regulatory approvals for drug screening products and services 102
TABLE 3 KEY PRODUCT AND SERVICE LAUNCHES FOR DRUG AND ALCOHOL TESTING, 2020-2022 102
TABLE 4 LIST OF REGULATORY AUTHORITIES FOR DRUG AND ALCOHOL TESTING PRODUCTS AND SERVICES 102
5.2.2 RESTRAINTS 103
5.2.2.1 Ban on alcohol consumption in Islamic countries 103
5.2.2.2 Prohibition on workplace drug testing 103
5.2.3 OPPORTUNITIES 103
5.2.3.1 Popularity of oral fluid testing 103
5.2.3.2 Introduction of fingerprint-based drug testing at workplaces 103
5.2.3.3 High growth opportunities in emerging economies 104
5.2.4 CHALLENGES 104
5.2.4.1 Accuracy and specificity concerns in breathalyzers 104
5.2.4.2 False positive and negative results in drug screening 104
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES 104
FIGURE 28 SHIFTS AND NEW REVENUE POCKETS FOR DRUG SCREENING MARKET 105
5.4 INDUSTRY TRENDS 105
5.4.1 INCREASING USE OF ORAL FLUID TESTING 105
5.4.2 GROWING NEED FOR SUBSTANCE TESTING PANELS 106
5.4.3 TECHNOLOGICAL ADVANCEMENTS 106
5.4.4 RISING FOCUS ON EMPLOYEE WELLNESS 107
5.5 VALUE CHAIN ANALYSIS 107
FIGURE 29 DRUG SCREENING MARKET: VALUE CHAIN ANALYSIS 108
5.6 ECOSYSTEM ANALYSIS 109
FIGURE 30 DRUG SCREENING MARKET: ECOSYSTEM MAP 109
TABLE 5 DRUG SCREENING MARKET: ROLE IN ECOSYSTEM 110
5.7 TECHNOLOGY ANALYSIS 110
5.7.1 KEY TECHNOLOGIES 110
5.7.1.1 Sweat patch testing 110
5.7.1.2 Alcohol ignition interlock device 111
5.7.1.3 Point-of-care testing 111
5.7.2 COMPLEMENTARY TECHNOLOGIES 111
5.7.2.1 Artificial Intelligence and machine learning 111
5.7.2.2 Biosensors 111
5.8 PORTER'S FIVE FORCES ANALYSIS 112
FIGURE 31 DRUG SCREENING MARKET: PORTER'S FIVE FORCES ANALYSIS 112
TABLE 6 DRUG SCREENING MARKET: PORTER'S FIVE FORCES ANALYSIS 113
5.8.1 INTENSITY OF COMPETITIVE RIVALRY 113
5.8.2 BARGAINING POWER OF SUPPLIERS 113
5.8.3 BARGAINING POWER OF BUYERS 113
5.8.4 THREAT OF SUBSTITUTES 114
5.8.5 THREAT OF NEW ENTRANTS 114
5.9 KEY STAKEHOLDERS AND BUYING CRITERIA 114
5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 114
FIGURE 32 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 114
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 115
5.9.2 KEY BUYING CRITERIA 115
FIGURE 33 KEY BUYING CRITERIA FOR TOP THREE END USERS 115
TABLE 8 KEY BUYING CRITERIA FOR TOP THREE END USERS 115
5.10 TARIFF AND REGULATORY ANALYSIS 116
5.10.1 TARIFF ANALYSIS 116
5.10.1.1 Tariff of chromatography instruments (HS code: 902720) 116
TABLE 9 TARIFF FOR CHROMATOGRAPHY INSTRUMENTS (HS CODE: 902720) 116
5.10.2 REGULATORY ANALYSIS 116
5.10.2.1 North America 116
5.10.2.1.1 US 116
TABLE 10 US: DRUG AND ALCOHOL TESTING REGULATIONS 118
5.10.2.2 Europe 118
5.10.2.2.1 Finland 118
5.10.2.2.2 Sweden 119
5.10.2.2.3 France 119
5.10.2.2.4 Italy 119
5.10.2.2.5 UK 119
5.10.2.2.6 Netherlands 119
5.10.2.2.7 Ireland 119
5.10.2.3 Asia Pacific 120
5.10.2.3.1 Japan 120
5.10.2.3.2 China 120
5.10.2.3.3 India 120
5.10.2.4 Australia and New Zealand 120
5.10.2.5 Latin America 121
5.10.2.6 Middle East & Africa 121
5.10.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 121
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123
TABLE 14 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 124
TABLE 15 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 124
5.11 PRICING ANALYSIS 124
5.11.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 124
FIGURE 34 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 125
TABLE 16 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 125
5.11.2 INDICATIVE PRICING ANALYSIS 125
5.12 PATENT ANALYSIS 126
5.12.1 PATENT PUBLICATION TRENDS FOR DRUG SCREENING PRODUCTS 126
FIGURE 35 PATENT PUBLICATION TRENDS IN DRUG SCREENING MARKET (JANUARY 2012-DECEMBER 2023) 126
5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 126
FIGURE 36 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DRUG SCREENING PATENTS (JANUARY 2012-NOVEMBER 2023) 127
FIGURE 37 TOP APPLICANT COUNTRIES/REGIONS FOR DRUG SCREENING PATENTS (JANUARY 2012-DECEMBER 2023) 128
TABLE 17 DRUG SCREENING MARKET: LIST OF MAJOR PATENTS 128
5.13 KEY CONFERENCES AND EVENTS IN 2024-2025 129
TABLE 18 DRUG SCREENING MARKET: DETAILED LIST OF KEY CONFERENCES AND EVENTS 129
5.14 CASE STUDY ANALYSIS 130
5.14.1 LEADING RETAIL CHAIN TO SAVE USD 1 MILLION WITH INSTANT ORAL FLUID DRUG SCREENING SOLUTIONS 130
5.14.2 PRE-EMPLOYMENT TESTING IN LONG-TERM CARE INDUSTRY 131
5.14.3 USE OF HAIR TESTING AND URINALYSIS IN TRANSPORTATION INDUSTRY 131
5.14.4 RANDOM TESTING IN MANUFACTURING AND AUTOMOTIVE INDUSTRIES 131
5.15 REVENUE MODEL ANALYSIS 132
5.15.1 SERVICE FEES 132
5.15.2 PRODUCT SALES 132
5.15.3 SERVICE PACKAGES 132
5.16 END USER ANALYSIS 133
5.16.1 UNMET NEEDS 133
TABLE 19 UNMET NEEDS IN DRUG SCREENING MARKET 133
5.16.2 END USER EXPECTATIONS 134
TABLE 20 END USER EXPECTATIONS IN DRUG SCREENING MARKET 134
5.17 FUNDING LANDSCAPE 135
FIGURE 38 FUNDING OF KEY PLAYERS IN DRUG SCREENING MARKET 135
5.18 TRADE ANALYSIS 136
FIGURE 39 IMPORT DATA FOR CHROMATOGRAPHY (HS CODE 902720), BY COUNTRY, 2019-2023 (USD) 136
FIGURE 40 EXPORT DATA FOR CHROMATOGRAPHY (HS CODE 902720), BY COUNTRY, 2019-2023 (USD MILLION) 136
6 DRUG SCREENING MARKET, BY PRODUCT & SERVICE 137
6.1 INTRODUCTION 138
TABLE 21 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 138
TABLE 22 DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 138
6.2 DRUG SCREENING SERVICES 138
TABLE 23 DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 139
TABLE 24 DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 139
TABLE 25 DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 139
TABLE 26 DRUG SCREENING SERVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 140
6.2.1 LABORATORY TESTING SERVICES 140
6.2.1.1 Higher accuracy and better reliability to propel segment growth 140
TABLE 27 LABORATORY TESTING SERVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 141
TABLE 28 LABORATORY TESTING SERVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 142
6.2.2 ON-SITE TESTING SERVICES 142
6.2.2.1 Increasing emphasis on workplace safety to drive market 142
TABLE 29 ON-SITE TESTING SERVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 143
TABLE 30 ON-SITE TESTING SERVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 143
6.3 DRUG SCREENING PRODUCTS 144
TABLE 31 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 144
TABLE 32 DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 144
TABLE 33 DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 145
TABLE 34 DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 146
6.3.1 ANALYTICAL INSTRUMENTS 146
6.3.1.1 Analytical instruments market, by type 146
TABLE 35 ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 147
TABLE 36 ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 147
TABLE 37 ANALYTICAL INSTRUMENT TYPES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 148
TABLE 38 ANALYTICAL INSTRUMENT TYPES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 149
6.3.1.1.1 Breathalyzers 149
TABLE 39 BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 150
TABLE 40 BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 150
TABLE 41 BREATHALYZERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 151
TABLE 42 BREATHALYZERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 152
6.3.1.1.1.1 Fuel-cell breathalyzers 152
6.3.1.1.1.1.1 High accuracy, sensitivity, and reliability to support segment growth 152
TABLE 43 FUEL-CELL BREATHALYZERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 153
TABLE 44 FUEL-CELL BREATHALYZERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 154
6.3.1.1.1.2 Semiconductor breathalyzers 154
6.3.1.1.1.2.1 Low cost and high accuracy to aid segment growth 154
TABLE 45 SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 155
TABLE 46 SEMICONDUCTOR BREATHALYZERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 156
6.3.1.1.1.3 Other breathalyzers 156
TABLE 47 OTHER BREATHALYZERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 157
TABLE 48 OTHER BREATHALYZERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 158
6.3.1.1.2 Immunoassay analyzers 158
6.3.1.1.2.1 Technological advancements and high demand for drug testing to drive segment 158
TABLE 49 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 159
TABLE 50 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 160
6.3.1.1.3 Chromatography instruments 160
6.3.1.1.3.1 More flexibility and higher accuracy to fuel segment growth 160
TABLE 51 CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 161
TABLE 52 CHROMATOGRAPHY INSTRUMENTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 162
6.3.1.2 Analytical instruments market, by modality 162
TABLE 53 ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 162
TABLE 54 ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 163
TABLE 55 ANALYTICAL INSTRUMENT MODALITIES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 163
TABLE 56 ANALYTICAL INSTRUMENT MODALITIES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 164
6.3.1.2.1 Hand-held drug screening products 164
6.3.1.2.1.1 Rising need for quick alcohol intoxication level assessment to drive segment 164
TABLE 57 HAND-HELD DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 165
TABLE 58 HAND-HELD DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 166
6.3.1.2.2 Benchtop drug screening products 166
6.3.1.2.2.1 High sensitivity and specificity to different drugs at low concentrations to boost segment growth 166
TABLE 59 BENCHTOP DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 167
TABLE 60 BENCHTOP DRUG SCREENING PRODUCTS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 168
6.3.2 RAPID TESTING DEVICES 168
TABLE 61 RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 168
TABLE 62 RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 169
TABLE 63 RAPID TESTING DEVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 169
TABLE 64 RAPID TESTING DEVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 170
6.3.2.1 Urine testing devices 170
TABLE 65 URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 170
TABLE 66 URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 171
TABLE 67 URINE TESTING DEVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 171
TABLE 68 URINE TESTING DEVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 172
6.3.2.1.1 Drug testing cups 172
6.3.2.1.1.1 Reduced chances of sample contamination to drive segment 172
TABLE 69 DRUG TESTING CUPS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 173
TABLE 70 DRUG TESTING CUPS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 174
6.3.2.1.2 Dip cards 174
6.3.2.1.2.1 No instrument requirements during urine testing to boost segment growth 174
TABLE 71 DIP CARDS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 175
TABLE 72 DIP CARDS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 176
6.3.2.1.3 Drug testing cassettes 176
6.3.2.1.3.1 Cost-effectiveness and quick results to augment segment growth 176
TABLE 73 DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 177
TABLE 74 DRUG TESTING CASSETTES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 178
6.3.2.2 Oral fluid testing devices 178
6.3.2.2.1 Low possibility of sample tampering to aid market growth 178
TABLE 75 ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 179
TABLE 76 ORAL FLUID TESTING DEVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 180
6.3.3 CONSUMABLES 180
TABLE 77 CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 180
TABLE 78 CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 181
TABLE 79 CONSUMABLES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 181
TABLE 80 CONSUMABLES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 182
6.3.3.1 Assay kits 182
6.3.3.1.1 Increased focus on rapid, inexpensive, and convenient sample screening methods to drive market 182
TABLE 81 ASSAY KITS MARKET, BY COUNTRY 2018-2022 (USD MILLION) 183
TABLE 82 ASSAY KITS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 184
6.3.3.2 Sample collection devices 184
6.3.3.2.1 Rising need for safe and efficient sample collection and transportation to propel market growth 184
TABLE 83 SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 185
TABLE 84 SAMPLE COLLECTION DEVICES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 186
6.3.3.3 Calibrators and controls 186
6.3.3.3.1 Growing need for quantitative comparison with actual test samples to fuel market growth 186
TABLE 85 CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 187
TABLE 86 CALIBRATORS AND CONTROLS MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 188
6.3.3.4 Other consumables 189
TABLE 87 OTHER CONSUMABLES MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 189
TABLE 88 OTHER CONSUMABLES MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 190
7 DRUG SCREENING MARKET, BY SAMPLE TYPE 191
7.1 INTRODUCTION 192
TABLE 89 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 192
TABLE 90 DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 192
7.2 URINE SAMPLES 193
7.2.1 EASE OF COLLECTION AND COST-EFFECTIVENESS TO SUPPORT MARKET GROWTH 193
TABLE 91 DRUG SCREENING MARKET FOR URINE SAMPLES, BY COUNTRY, 2018-2022 (USD MILLION) 193
TABLE 92 DRUG SCREENING MARKET FOR URINE SAMPLES, BY COUNTRY, 2023-2029 (USD MILLION) 194
7.3 BREATH SAMPLES 194
7.3.1 RISING NUMBER OF DRIVING-UNDER-INFLUENCE CASES TO PROPEL MARKET GROWTH 194
TABLE 93 DRUG SCREENING MARKET FOR BREATH SAMPLES, BY COUNTRY, 2018-2022 (USD MILLION) 195
TABLE 94 DRUG SCREENING MARKET FOR BREATH SAMPLES, BY COUNTRY, 2023-2029 (USD MILLION) 196
7.4 ORAL FLUID SAMPLES 196
7.4.1 NON-INVASIVE SAMPLE COLLECTION AND LOW CHANCE OF ADULTERATION TO BOOST MARKET GROWTH 196
TABLE 95 DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2018-2022 (USD MILLION) 197
TABLE 96 DRUG SCREENING MARKET FOR ORAL FLUID SAMPLES, BY COUNTRY, 2023-2029 (USD MILLION) 198
7.5 HAIR SAMPLES 198
7.5.1 DETAILED INSIGHTS INTO LONG-TERM DRUG USE TO SPUR MARKET GROWTH 198
TABLE 97 DRUG SCREENING MARKET FOR HAIR SAMPLES, BY COUNTRY, 2018-2022 (USD MILLION) 199
TABLE 98 DRUG SCREENING MARKET FOR HAIR SAMPLES, BY COUNTRY, 2023-2029 (USD MILLION) 200
7.6 OTHER SAMPLES 200
TABLE 99 DRUG SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2018-2022 (USD MILLION) 201
TABLE 100 DRUG SCREENING MARKET FOR OTHER SAMPLES, BY COUNTRY, 2023-2029 (USD MILLION) 202
8 DRUG SCREENING MARKET, BY DRUG TYPE 203
8.1 INTRODUCTION 204
TABLE 101 DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 204
TABLE 102 DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 204
8.2 CANNABIS 205
8.2.1 INCREASING LEGALIZATION FOR MEDICAL AND RECREATIONAL PURPOSES TO DRIVE MARKET 205
TABLE 103 DRUG SCREENING MARKET FOR CANNABIS, BY COUNTRY, 2018-2022 (USD MILLION) 205
TABLE 104 DRUG SCREENING MARKET FOR CANNABIS, BY COUNTRY, 2023-2029 (USD MILLION) 206
8.3 ALCOHOL 206
8.3.1 RISING REGULATORY COMPLIANCE IN SAFETY-SENSITIVE INDUSTRIES TO DRIVE MARKET 206
TABLE 105 DRUG SCREENING MARKET FOR ALCOHOL, BY COUNTRY, 2018-2022 (USD MILLION) 207
TABLE 106 DRUG SCREENING MARKET FOR ALCOHOL, BY COUNTRY, 2023-2029 (USD MILLION) 208
8.4 COCAINE 208
8.4.1 ILLICIT NATURE AND ASSOCIATED HEALTH RISKS TO FUEL MARKET GROWTH 208
TABLE 107 DRUG SCREENING MARKET FOR COCAINE, BY COUNTRY, 2018-2022 (USD MILLION) 209
TABLE 108 DRUG SCREENING MARKET FOR COCAINE, BY COUNTRY, 2023-2029 (USD MILLION) 210
8.5 OPIOIDS 210
8.5.1 INCREASING CASES OF OPIOIDS ADDICTION TO AID MARKET GROWTH 210
TABLE 109 DRUG SCREENING MARKET FOR OPIOIDS, BY COUNTRY, 2018-2022 (USD MILLION) 211
TABLE 110 DRUG SCREENING MARKET FOR OPIOIDS, BY COUNTRY, 2023-2029 (USD MILLION) 211
8.6 AMPHETAMINE AND METHAMPHETAMINE 212
8.6.1 GROWING USE AMONG EDUCATION SERVICE EMPLOYEES TO AUGMENT MARKET GROWTH 212
TABLE 111 DRUG SCREENING MARKET FOR AMPHETAMINE AND METHAMPHETAMINE, BY COUNTRY, 2018-2022 (USD MILLION) 212
TABLE 112 DRUG SCREENING MARKET FOR AMPHETAMINE AND METHAMPHETAMINE, BY COUNTRY, 2023-2029 (USD MILLION) 213
8.7 OTHER DRUGS 213
TABLE 113 DRUG SCREENING MARKET FOR OTHER DRUGS, BY COUNTRY, 2018-2022 (USD MILLION) 214
TABLE 114 DRUG SCREENING MARKET FOR OTHER DRUGS, BY COUNTRY, 2023-2029 (USD MILLION) 215
9 DRUG SCREENING MARKET, BY END USER 216
9.1 INTRODUCTION 217
TABLE 115 DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 217
TABLE 116 DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 218
9.2 DRUG TESTING LABORATORIES 218
9.2.1 DRUG TESTING LABORATORIES TO COMMAND HIGHEST GROWTH RATE DURING STUDY PERIOD 218
TABLE 117 DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2018-2022 (USD MILLION) 219
TABLE 118 DRUG SCREENING MARKET FOR DRUG TESTING LABORATORIES, BY COUNTRY, 2023-2029 (USD MILLION) 220
9.3 WORKPLACES 220
9.3.1 INCREASED FOCUS ON RANDOM DRUG TESTING AT OFFICES TO FUEL MARKET GROWTH 220
TABLE 119 DRUG SCREENING MARKET FOR WORKPLACES, BY COUNTRY, 2018-2022 (USD MILLION) 221
TABLE 120 DRUG SCREENING MARKET FOR WORKPLACES, BY COUNTRY, 2023-2029 (USD MILLION) 222
9.4 CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES 222
9.4.1 GROWING GOVERNMENT FOCUS ON DRUG TESTING TO DRIVE MARKET 222
TABLE 121 DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2018-2022 (USD MILLION) 223
TABLE 122 DRUG SCREENING MARKET FOR CRIMINAL JUSTICE SYSTEMS AND LAW ENFORCEMENT AGENCIES, BY COUNTRY, 2023-2029 (USD MILLION) 224
9.5 HOSPITALS 224
9.5.1 RISING DRUG ABUSE CASES TO AID MARKET GROWTH 224
TABLE 123 DRUG SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2018-2022 (USD MILLION) 225
TABLE 124 DRUG SCREENING MARKET FOR HOSPITALS, BY COUNTRY, 2023-2029 (USD MILLION) 226
9.6 DRUG TREATMENT CENTERS 226
9.6.1 GROWING GOVERNMENT SUPPORT AGAINST DRUG ABUSE TO DRIVE MARKET 226
TABLE 125 DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2018-2022 (USD MILLION) 227
TABLE 126 DRUG SCREENING MARKET FOR DRUG TREATMENT CENTERS, BY COUNTRY, 2023-2029 (USD MILLION) 228
9.7 INDIVIDUAL USERS 228
9.7.1 STRINGENT REGULATIONS AND PERSONAL SAFETY CONCERNS TO DRIVE MARKET 228
TABLE 127 DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2018-2022 (USD MILLION) 229
TABLE 128 DRUG SCREENING MARKET FOR INDIVIDUAL USERS, BY COUNTRY, 2023-2029 (USD MILLION) 230
9.8 PAIN MANAGEMENT CENTERS 230
9.8.1 GROWING ABUSE OF PRESCRIPTION DRUGS TO DRIVE MARKET 230
TABLE 129 DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2018-2022 (USD MILLION) 231
TABLE 130 DRUG SCREENING MARKET FOR PAIN MANAGEMENT CENTERS, BY COUNTRY, 2023-2029 (USD MILLION) 232
9.9 SCHOOLS AND COLLEGES 232
9.9.1 RISING FOCUS ON DRUG ABUSE TESTING PROGRAMS TO SUPPORT MARKET GROWTH 232
TABLE 131 DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2018-2022 (USD MILLION) 233
TABLE 132 DRUG SCREENING MARKET FOR SCHOOLS AND COLLEGES, BY COUNTRY, 2023-2029 (USD MILLION) 234
9.10 OTHER END USERS 234
TABLE 133 DRUG SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2018-2022 (USD MILLION) 235
TABLE 134 DRUG SCREENING MARKET FOR OTHER END USERS, BY COUNTRY, 2023-2029 (USD MILLION) 236
10 DRUG SCREENING MARKET, BY REGION 237
10.1 INTRODUCTION 238
TABLE 135 DRUG SCREENING MARKET, BY REGION, 2018-2022 (USD MILLION) 238
TABLE 136 DRUG SCREENING MARKET, BY REGION, 2023-2029 (USD MILLION) 238
10.2 NORTH AMERICA 239
FIGURE 41 NORTH AMERICA: DRUG SCREENING MARKET SNAPSHOT 239
TABLE 137 NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 240
TABLE 138 NORTH AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 240
TABLE 139 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 240
TABLE 140 NORTH AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 241
TABLE 141 NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 241
TABLE 142 NORTH AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 241
TABLE 143 NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 242
TABLE 144 NORTH AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 242
TABLE 145 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 242
TABLE 146 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 243
TABLE 147 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 243
TABLE 148 NORTH AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 243
TABLE 149 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 244
TABLE 150 NORTH AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 244
TABLE 151 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 244
TABLE 152 NORTH AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 245
TABLE 153 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 245
TABLE 154 NORTH AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 245
TABLE 155 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 246
TABLE 156 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 246
TABLE 157 NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 246
TABLE 158 NORTH AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 247
TABLE 159 NORTH AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 247
TABLE 160 NORTH AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 248
TABLE 161 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 248
TABLE 162 NORTH AMERICA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 249
10.2.1 NORTH AMERICA: RECESSION IMPACT 249
10.2.2 US 250
10.2.2.1 US to dominate North American drug screening market during study period 250
TABLE 163 US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 250
TABLE 164 US: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 251
TABLE 165 US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 251
TABLE 166 US: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 251
TABLE 167 US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 251
TABLE 168 US: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 252
TABLE 169 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 252
TABLE 170 US: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 252
TABLE 171 US: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 253
TABLE 172 US: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 253
TABLE 173 US: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 253
TABLE 174 US: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 254
TABLE 175 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 254
TABLE 176 US: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 254
TABLE 177 US: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 255
TABLE 178 US: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 255
TABLE 179 US: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 255
TABLE 180 US: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 256
TABLE 181 US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 256
TABLE 182 US: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 256
TABLE 183 US: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 257
TABLE 184 US: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 257
TABLE 185 US: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 258
TABLE 186 US: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 258
10.2.3 CANADA 259
10.2.3.1 Increasing drunk driving-related accidental deaths to support market growth 259
TABLE 187 CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 259
TABLE 188 CANADA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 260
TABLE 189 CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 260
TABLE 190 CANADA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 260
TABLE 191 CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 261
TABLE 192 CANADA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 261
TABLE 193 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 261
TABLE 194 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 262
TABLE 195 CANADA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 262
TABLE 196 CANADA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 262
TABLE 197 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 263
TABLE 198 CANADA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 263
TABLE 199 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 263
TABLE 200 CANADA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 264
TABLE 201 CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 264
TABLE 202 CANADA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 264
TABLE 203 CANADA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 265
TABLE 204 CANADA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 265
TABLE 205 CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 265
TABLE 206 CANADA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 266
TABLE 207 CANADA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 266
TABLE 208 CANADA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 267
TABLE 209 CANADA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 267
TABLE 210 CANADA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 268
10.3 EUROPE 268
TABLE 211 EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 269
TABLE 212 EUROPE: DRUG SCREENING MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 269
TABLE 213 EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 269
TABLE 214 EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 270
TABLE 215 EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 270
TABLE 216 EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 270
TABLE 217 EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 271
TABLE 218 EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 271
TABLE 219 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 271
TABLE 220 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 272
TABLE 221 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 272
TABLE 222 EUROPE: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 272
TABLE 223 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 273
TABLE 224 EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 273
TABLE 225 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 273
TABLE 226 EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 274
TABLE 227 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 274
TABLE 228 EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 274
TABLE 229 EUROPE: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 275
TABLE 230 EUROPE: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 275
TABLE 231 EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 275
TABLE 232 EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 276
TABLE 233 EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 276
TABLE 234 EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 277
TABLE 235 EUROPE: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 277
TABLE 236 EUROPE: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 278

10.3.1 EUROPE: RECESSION IMPACT 278
10.3.2 GERMANY 278
10.3.2.1 Increasing number of drug-related deaths to drive market 278
TABLE 237 GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 279
TABLE 238 GERMANY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 279
TABLE 239 GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 279
TABLE 240 GERMANY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 280
TABLE 241 GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 280
TABLE 242 GERMANY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 280
TABLE 243 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 281
TABLE 244 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 281
TABLE 245 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 281
TABLE 246 GERMANY: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 282
TABLE 247 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 282
TABLE 248 GERMANY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 282
TABLE 249 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 283
TABLE 250 GERMANY: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 283
TABLE 251 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 283
TABLE 252 GERMANY: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 284
TABLE 253 GERMANY: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 284
TABLE 254 GERMANY: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 284
TABLE 255 GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 285
TABLE 256 GERMANY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 285
TABLE 257 GERMANY: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 286
TABLE 258 GERMANY: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 286
TABLE 259 GERMANY: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 287
TABLE 260 GERMANY: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 287
10.3.3 FRANCE 288
10.3.3.1 Robust healthcare infrastructure and proactive approach toward public health to aid market growth 288
TABLE 261 FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 288
TABLE 262 FRANCE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 288
TABLE 263 FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 289
TABLE 264 FRANCE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 289
TABLE 265 FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 289
TABLE 266 FRANCE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 290
TABLE 267 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 290
TABLE 268 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 290
TABLE 269 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 291
TABLE 270 FRANCE: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 291
TABLE 271 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 291
TABLE 272 FRANCE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 292
TABLE 273 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 292
TABLE 274 FRANCE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 292
TABLE 275 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 293
TABLE 276 FRANCE: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 293
TABLE 277 FRANCE: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 293
TABLE 278 FRANCE: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 294
TABLE 279 FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 294
TABLE 280 FRANCE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 294
TABLE 281 FRANCE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 295
TABLE 282 FRANCE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 295
TABLE 283 FRANCE: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 296
TABLE 284 FRANCE: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 296
10.3.4 UK 297
10.3.4.1 Increase in illicit drug consumption to augment market growth 297
TABLE 285 UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 297
TABLE 286 UK: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 297
TABLE 287 UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 298
TABLE 288 UK: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 298
TABLE 289 UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 298
TABLE 290 UK: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 298
TABLE 291 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 299
TABLE 292 UK: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 299
TABLE 293 UK: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 299
TABLE 294 UK: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 300
TABLE 295 UK: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 300
TABLE 296 UK: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 300
TABLE 297 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 301
TABLE 298 UK: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 301
TABLE 299 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 301
TABLE 300 UK: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 302
TABLE 301 UK: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 302
TABLE 302 UK: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 302
TABLE 303 UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 303
TABLE 304 UK: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 303
TABLE 305 UK: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 304
TABLE 306 UK: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 304
TABLE 307 UK: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 305
TABLE 308 UK: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 305
10.3.5 ITALY 306
10.3.5.1 Growing consumption of illegal psychoactive substances and drugs among minors to boost market growth 306
TABLE 309 ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 306
TABLE 310 ITALY: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 306
TABLE 311 ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 307
TABLE 312 ITALY: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 307
TABLE 313 ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 307
TABLE 314 ITALY: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 308
TABLE 315 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 308
TABLE 316 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 308
TABLE 317 ITALY: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 309
TABLE 318 ITALY: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 309
TABLE 319 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 309
TABLE 320 ITALY: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 310
TABLE 321 ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 310
TABLE 322 ITALY: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 310
TABLE 323 ITALY: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 311
TABLE 324 ITALY: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 311
TABLE 325 ITALY: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 311
TABLE 326 ITALY: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 312
TABLE 327 ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 312
TABLE 328 ITALY: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 312
TABLE 329 ITALY: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 313
TABLE 330 ITALY: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 313
TABLE 331 ITALY: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 314
TABLE 332 ITALY: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 314
10.3.6 SPAIN 315
10.3.6.1 Stringent government regulations and high consumption of alcohol to aid market growth 315
TABLE 333 SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 315
TABLE 334 SPAIN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 315
TABLE 335 SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 316
TABLE 336 SPAIN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 316
TABLE 337 SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 316
TABLE 338 SPAIN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 317
TABLE 339 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 317
TABLE 340 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 317
TABLE 341 SPAIN: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 318
TABLE 342 SPAIN: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 318
TABLE 343 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 318
TABLE 344 SPAIN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 319
TABLE 345 SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 319
TABLE 346 SPAIN: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 319
TABLE 347 SPAIN: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 320
TABLE 348 SPAIN: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 320
TABLE 349 SPAIN: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 320
TABLE 350 SPAIN: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 321
TABLE 351 SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 321
TABLE 352 SPAIN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 321
TABLE 353 SPAIN: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 322
TABLE 354 SPAIN: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 322
TABLE 355 SPAIN: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 323
TABLE 356 SPAIN: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 323
10.3.7 REST OF EUROPE 324
TABLE 357 REST OF EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 324
TABLE 358 REST OF EUROPE: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 324
TABLE 359 REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 325
TABLE 360 REST OF EUROPE: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 325
TABLE 361 REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 325
TABLE 362 REST OF EUROPE: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 326
TABLE 363 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, 2018-2022 (USD MILLION) 326
TABLE 364 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 326
TABLE 365 REST OF EUROPE: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 327
TABLE 366 REST OF EUROPE: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 327
TABLE 367 REST OF EUROPE: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 327
TABLE 368 REST OF EUROPE ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 328
TABLE 369 REST OF EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 328
TABLE 370 REST OF EUROPE: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 328
TABLE 371 REST OF EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 329
TABLE 372 REST OF EUROPE: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 329
TABLE 373 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 329
TABLE 374 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 330
TABLE 375 REST OF EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 330
TABLE 376 REST OF EUROPE: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 331
TABLE 377 REST OF EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 331
TABLE 378 REST OF EUROPE: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 332
TABLE 379 REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 332
TABLE 380 REST OF EUROPE: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 333
10.4 ASIA PACIFIC 333
FIGURE 42 ASIA PACIFIC: DRUG SCREENING MARKET SNAPSHOT 334
TABLE 381 ASIA PACIFIC: DRUG SCREENING MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 334
TABLE 382 ASIA PACIFIC: DRUG SCREENING MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 335
TABLE 383 ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 335
TABLE 384 ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 335
TABLE 385 ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 336
TABLE 386 ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 336
TABLE 387 ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 336
TABLE 388 ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 337
TABLE 389 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 337
TABLE 390 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 337
TABLE 391 ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 338
TABLE 392 ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 338
TABLE 393 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 338
TABLE 394 ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 339
TABLE 395 ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 339
TABLE 396 ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 339
TABLE 397 ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 340
TABLE 398 ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 340
TABLE 399 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 340
TABLE 400 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 341
TABLE 401 ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 341
TABLE 402 ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 341
TABLE 403 ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 342
TABLE 404 ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 342
TABLE 405 ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 343
TABLE 406 ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 343
10.4.1 ASIA PACIFIC: RECESSION IMPACT 344
10.4.2 JAPAN 344
10.4.2.1 Stringent laws for drug abuse and increased government support to drive market 344
TABLE 407 JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 344
TABLE 408 JAPAN: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 345
TABLE 409 JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 345
TABLE 410 JAPAN: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 345
TABLE 411 JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 345
TABLE 412 JAPAN: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 346
TABLE 413 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 346
TABLE 414 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 346
TABLE 415 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 347
TABLE 416 JAPAN: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 347
TABLE 417 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 347
TABLE 418 JAPAN: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 348
TABLE 419 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 348
TABLE 420 JAPAN: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 348
TABLE 421 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 349
TABLE 422 JAPAN: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 349
TABLE 423 JAPAN: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 349
TABLE 424 JAPAN: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 350
TABLE 425 JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 350
TABLE 426 JAPAN: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 350
TABLE 427 JAPAN: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 351
TABLE 428 JAPAN: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 351
TABLE 429 JAPAN: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 352
TABLE 430 JAPAN: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 352
10.4.3 CHINA 353
10.4.3.1 Increasing alcohol consumption and rising cases of drunk driving to fuel market growth 353
TABLE 431 CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 353
TABLE 432 CHINA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 353
TABLE 433 CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 354
TABLE 434 CHINA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 354
TABLE 435 CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 354
TABLE 436 CHINA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 355
TABLE 437 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 355
TABLE 438 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 355
TABLE 439 CHINA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 356
TABLE 440 CHINA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 356
TABLE 441 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 356
TABLE 442 CHINA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 357
TABLE 443 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 357
TABLE 444 CHINA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 357
TABLE 445 CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 358
TABLE 446 CHINA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 358
TABLE 447 CHINA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 358
TABLE 448 CHINA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 359
TABLE 449 CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 359
TABLE 450 CHINA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 359
TABLE 451 CHINA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 360
TABLE 452 CHINA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 360
TABLE 453 CHINA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 361
TABLE 454 CHINA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 361
10.4.4 INDIA 362
10.4.4.1 Increase in illicit drug users and improved healthcare infrastructure to support market growth 362
TABLE 455 INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 362
TABLE 456 INDIA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 362
TABLE 457 INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 363
TABLE 458 INDIA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 363
TABLE 459 INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 363
TABLE 460 INDIA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 364
TABLE 461 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 364
TABLE 462 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 364
TABLE 463 INDIA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 365
TABLE 464 INDIA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 365
TABLE 465 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 365
TABLE 466 INDIA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 366
TABLE 467 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 366
TABLE 468 INDIA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 366
TABLE 469 INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 367
TABLE 470 INDIA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 367
TABLE 471 INDIA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 367
TABLE 472 INDIA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 368
TABLE 473 INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 368
TABLE 474 INDIA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 368
TABLE 475 INDIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 369
TABLE 476 INDIA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 369
TABLE 477 INDIA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 370
TABLE 478 INDIA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 370
10.4.5 REST OF ASIA PACIFIC 371
TABLE 479 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 371
TABLE 480 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 371
TABLE 481 REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 372
TABLE 482 REST OF ASIA PACIFIC: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 372
TABLE 483 REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 372
TABLE 484 REST OF ASIA PACIFIC: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 373
TABLE 485 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 373
TABLE 486 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 373
TABLE 487 REST OF ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 374
TABLE 488 REST OF ASIA PACIFIC: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 374
TABLE 489 REST OF ASIA PACIFIC: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 374
TABLE 490 REST OF ASIA PACIFIC ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 375
TABLE 491 REST OF ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 375
TABLE 492 REST OF ASIA PACIFIC: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 375
TABLE 493 REST OF ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 376
TABLE 494 REST OF ASIA PACIFIC: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 376
TABLE 495 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 376
TABLE 496 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 377
TABLE 497 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 377
TABLE 498 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 377
TABLE 499 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 378
TABLE 500 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 378
TABLE 501 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 379
TABLE 502 REST OF ASIA PACIFIC: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 379

10.5 LATIN AMERICA 380
TABLE 503 LATIN AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2018-2022 (USD MILLION) 380
TABLE 504 LATIN AMERICA: DRUG SCREENING MARKET, BY COUNTRY, 2023-2029 (USD MILLION) 380
TABLE 505 LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 381
TABLE 506 LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 381
TABLE 507 LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 381
TABLE 508 LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 382
TABLE 509 LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 382
TABLE 510 LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 382
TABLE 511 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 383
TABLE 512 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 383
TABLE 513 LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 383
TABLE 514 LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 384
TABLE 515 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 384
TABLE 516 LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 384
TABLE 517 LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 385
TABLE 518 LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 385
TABLE 519 LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 385
TABLE 520 LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 386
TABLE 521 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 386
TABLE 522 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 386
TABLE 523 LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 387
TABLE 524 LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 387
TABLE 525 LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 388
TABLE 526 LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 388
TABLE 527 LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 389
TABLE 528 LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 389
10.5.1 LATIN AMERICA: RECESSION IMPACT 390
10.5.2 BRAZIL 390
10.5.2.1 Growing emphasis on substance abuse prevention at workplaces to drive market 390
TABLE 529 BRAZIL: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 390
TABLE 530 BRAZIL: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 391
TABLE 531 BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 391
TABLE 532 BRAZIL: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 391
TABLE 533 BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 392
TABLE 534 BRAZIL: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 392
TABLE 535 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 392
TABLE 536 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 393
TABLE 537 BRAZIL: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 393
TABLE 538 BRAZIL: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 393
TABLE 539 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 394
TABLE 540 BRAZIL: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 394
TABLE 541 BRAZIL: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 394
TABLE 542 BRAZIL: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 394
TABLE 543 BRAZIL: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 395
TABLE 544 BRAZIL: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 395
TABLE 545 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 395
TABLE 546 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 396
TABLE 547 BRAZIL: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 396
TABLE 548 BRAZIL: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 396
TABLE 549 BRAZIL: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 397
TABLE 550 BRAZIL: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 397
TABLE 551 BRAZIL: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 398
TABLE 552 BRAZIL: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 398
10.5.3 MEXICO 399
10.5.3.1 Increasing government focus on controlling drug trafficking and substance abuse to propel market growth 399
TABLE 553 MEXICO: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 399
TABLE 554 MEXICO: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 399
TABLE 555 MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 400
TABLE 556 MEXICO: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 400
TABLE 557 MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 400
TABLE 558 MEXICO: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 401
TABLE 559 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 401
TABLE 560 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 401
TABLE 561 MEXICO: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 402
TABLE 562 MEXICO: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 402
TABLE 563 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 402
TABLE 564 MEXICO: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 403
TABLE 565 MEXICO: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 403
TABLE 566 MEXICO: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 403
TABLE 567 MEXICO: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 404
TABLE 568 MEXICO: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 404
TABLE 569 MEXICO: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 404
TABLE 570 MEXICO: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 405
TABLE 571 MEXICO: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 405
TABLE 572 MEXICO: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 405
TABLE 573 MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 406
TABLE 574 MEXICO: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 406
TABLE 575 MEXICO: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 407
TABLE 576 MEXICO: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 407
10.5.4 REST OF LATIN AMERICA 408
TABLE 577 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 408
TABLE 578 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 408
TABLE 579 REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 409
TABLE 580 REST OF LATIN AMERICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 409
TABLE 581 REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 409
TABLE 582 REST OF LATIN AMERICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 410
TABLE 583 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 410
TABLE 584 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 410
TABLE 585 REST OF LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 411
TABLE 586 REST OF LATIN AMERICA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 411
TABLE 587 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 411
TABLE 588 REST OF LATIN AMERICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 412
TABLE 589 REST OF LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 412
TABLE 590 REST OF LATIN AMERICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 412
TABLE 591 REST OF LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 413
TABLE 592 REST OF LATIN AMERICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 413
TABLE 593 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 413
TABLE 594 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 414
TABLE 595 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 414
TABLE 596 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 414
TABLE 597 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 415
TABLE 598 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 415
TABLE 599 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 416
TABLE 600 REST OF LATIN AMERICA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 416
10.6 MIDDLE EAST & AFRICA 417
TABLE 601 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY REGION, 2018-2022 (USD MILLION) 417
TABLE 602 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY REGION, 2023-2029 (USD MILLION) 417
TABLE 603 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 418
TABLE 604 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 418
TABLE 605 MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 418
TABLE 606 MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 419
TABLE 607 MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 419
TABLE 608 MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 419
TABLE 609 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 420
TABLE 610 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 420
TABLE 611 MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 420
TABLE 612 MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 421
TABLE 613 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 421
TABLE 614 MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 421
TABLE 615 MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 422
TABLE 616 MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 422
TABLE 617 MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 422
TABLE 618 MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 423
TABLE 619 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 423
TABLE 620 MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 423
TABLE 621 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 424
TABLE 622 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 424
TABLE 623 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 424
TABLE 624 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 425
TABLE 625 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 425
TABLE 626 MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 426
10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT 426
10.6.2 GCC COUNTRIES 426
10.6.2.1 Technological advancements in drug screening to drive market 426
TABLE 627 GCC COUNTRIES: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 427
TABLE 628 GCC COUNTRIES: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 427
TABLE 629 GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 427
TABLE 630 GCC COUNTRIES: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 428
TABLE 631 GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 428
TABLE 632 GCC COUNTRIES: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 428
TABLE 633 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 429
TABLE 634 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 429
TABLE 635 GCC COUNTRIES: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 429
TABLE 636 GCC COUNTRIES: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 430
TABLE 637 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 430
TABLE 638 GCC COUNTRIES: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 430
TABLE 639 GCC COUNTRIES: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 431
TABLE 640 GCC COUNTRIES: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 431
TABLE 641 GCC COUNTRIES: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 431
TABLE 642 GCC COUNTRIES: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 431
TABLE 643 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 432
TABLE 644 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 432
TABLE 645 GCC COUNTRIES: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 432
TABLE 646 GCC COUNTRIES: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 433
TABLE 647 GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 433
TABLE 648 GCC COUNTRIES: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 434
TABLE 649 GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 434
TABLE 650 GCC COUNTRIES: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 435
10.6.3 REST OF MIDDLE EAST & AFRICA 435
TABLE 651 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2018-2022 (USD MILLION) 436
TABLE 652 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY PRODUCT & SERVICE, 2023-2029 (USD MILLION) 436
TABLE 653 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 436
TABLE 654 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING SERVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 437
TABLE 655 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 437
TABLE 656 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING PRODUCTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 437
TABLE 657 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018-2022 (USD MILLION) 438
TABLE 658 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2023-2029 (USD MILLION) 438
TABLE 659 REST OF MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2018-2022 (USD MILLION) 438
TABLE 660 REST OF MIDDLE EAST & AFRICA: BREATHALYZERS MARKET, BY TYPE, 2023-2029 (USD MILLION) 439
TABLE 661 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2018-2022 (USD MILLION) 439
TABLE 662 REST OF MIDDLE EAST & AFRICA: ANALYTICAL INSTRUMENTS MARKET, BY MODALITY, 2023-2029 (USD MILLION) 439
TABLE 663 REST OF MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 440
TABLE 664 REST OF MIDDLE EAST & AFRICA: RAPID TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 440
TABLE 665 REST OF MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2018-2022 (USD MILLION) 440
TABLE 666 REST OF MIDDLE EAST & AFRICA: URINE TESTING DEVICES MARKET, BY TYPE, 2023-2029 (USD MILLION) 441
TABLE 667 REST OF MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2018-2022 (USD MILLION) 441
TABLE 668 REST OF MIDDLE EAST & AFRICA: CONSUMABLES MARKET, BY TYPE, 2023-2029 (USD MILLION) 441
TABLE 669 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2018-2022 (USD MILLION) 442
TABLE 670 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY SAMPLE TYPE, 2023-2029 (USD MILLION) 442
TABLE 671 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2018-2022 (USD MILLION) 443
TABLE 672 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY DRUG TYPE, 2023-2029 (USD MILLION) 443
TABLE 673 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2018-2022 (USD MILLION) 444
TABLE 674 REST OF MIDDLE EAST & AFRICA: DRUG SCREENING MARKET, BY END USER, 2023-2029 (USD MILLION) 444
11 COMPETITIVE LANDSCAPE 445
11.1 INTRODUCTION 445
11.2 KEY PLAYER STRATEGY/RIGHT TO WIN 445
FIGURE 43 DRUG SCREENING MARKET: STRATEGIES ADOPTED 446
11.3 REVENUE ANALYSIS 447
FIGURE 44 DRUG SCREENING MARKET: REVENUE ANALYSIS (2019-2023) 447
11.4 MARKET SHARE ANALYSIS 447
FIGURE 45 DRUG SCREENING MARKET: MARKET SHARE ANALYSIS (2023) 448
TABLE 675 DRUG SCREENING MARKET: DEGREE OF COMPETITION 448
11.4.1 MARKET RANKING ANALYSIS 449
FIGURE 46 DRUG SCREENING MARKET RANKING, BY KEY PLAYER (2023) 449
11.4.1.1 Laboratory Corporation of America Holdings 449
11.4.1.2 Quest Diagnostics 449
11.4.1.3 Abbott 450
?
11.5 BRAND/PRODUCT COMPARISON 450
FIGURE 47 DRUG SCREENING MARKET: BRAND/PRODUCT COMPARISON 450
11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 451
11.6.1 STARS 451
11.6.2 EMERGING LEADERS 451
11.6.3 PERVASIVE PLAYERS 451
11.6.4 PARTICIPANTS 451
FIGURE 48 DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 452
11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 453
11.6.5.1 Overall footprint 453
TABLE 676 DRUG SCREENING MARKET: OVERALL FOOTPRINT 453
11.6.5.2 Product footprint 454
TABLE 677 DRUG SCREENING MARKET: PRODUCT FOOTPRINT 454
11.6.5.3 Service footprint 455
TABLE 678 DRUG SCREENING MARKET: SERVICE FOOTPRINT 455
11.6.5.4 Sample type footprint 456
TABLE 679 DRUG SCREENING MARKET: SAMPLE TYPE FOOTPRINT 456
11.6.5.5 Drug type footprint 457
TABLE 680 DRUG SCREENING MARKET: DRUG TYPE FOOTPRINT 457
11.6.5.6 Regional footprint 458
TABLE 681 DRUG SCREENING MARKET: REGIONAL FOOTPRINT 458
11.7 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023 459
11.7.1 PROGRESSIVE COMPANIES 459
11.7.2 RESPONSIVE COMPANIES 459
11.7.3 DYNAMIC COMPANIES 459
11.7.4 STARTING BLOCKS 459
FIGURE 49 DRUG SCREENING MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023 460
11.7.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023 461
TABLE 682 DRUG SCREENING MARKET: DETAILED LIST OF KEY START-UPS/SMES 461
TABLE 683 DRUG SCREENING MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES 462
11.8 VALUATION AND FINANCIAL METRICS 462
FIGURE 50 EV/EBITDA OF KEY VENDORS 462
FIGURE 51 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 463
11.9 COMPETITIVE SCENARIO 463
11.9.1 PRODUCT/SERVICE LAUNCHES AND DEVELOPMENTS 463
TABLE 684 DRUG SCREENING MARKET: PRODUCT/SERVICE LAUNCHES AND DEVELOPMENTS, JANUARY 2021-APRIL 2024 463
11.9.2 DEALS 465
TABLE 685 DRUG SCREENING MARKET: DEALS, JANUARY 2021-APRIL 2024 465
11.9.3 OTHER DEVELOPMENTS 466
TABLE 686 DRUG SCREENING MARKET: OTHER DEVELOPMENTS, JANUARY 2021-APRIL 2024 466
12 COMPANY PROFILES 467
12.1 KEY PLAYERS 467
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 LABORATORY CORPORATION OF AMERICA HOLDINGS 467
TABLE 687 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY OVERVIEW 467
FIGURE 52 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2023) 468
TABLE 688 LABORATORY CORPORATION OF AMERICA HOLDINGS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 468
TABLE 689 LABORATORY CORPORATION OF AMERICA HOLDINGS: DEALS 469
12.1.2 QUEST DIAGNOSTICS 471
TABLE 690 QUEST DIAGNOSTICS: COMPANY OVERVIEW 471
FIGURE 53 QUEST DIAGNOSTICS: COMPANY SNAPSHOT (2023) 471
TABLE 691 QUEST DIAGNOSTICS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 472
TABLE 692 QUEST DIAGNOSTICS: SERVICE LAUNCHES 472
TABLE 693 QUEST DIAGNOSTICS: DEALS 473
12.1.3 ABBOTT 475
TABLE 694 ABBOTT: COMPANY OVERVIEW 475
FIGURE 54 ABBOTT: COMPANY SNAPSHOT (2023) 476
TABLE 695 ABBOTT: PRODUCTS/SERVICES/SOLUTIONS OFFERED 476
12.1.4 ORASURE TECHNOLOGIES INC. 479
TABLE 696 ORASURE TECHNOLOGIES INC.: COMPANY OVERVIEW 479
FIGURE 55 ORASURE TECHNOLOGIES INC.: COMPANY SNAPSHOT (2023) 480
TABLE 697 ORASURE TECHNOLOGIES INC.: PRODUCTS/SERVICES/
SOLUTIONS OFFERED 480
TABLE 698 ORASURE TECHNOLOGIES INC.: DEALS 481
12.1.5 ALFA SCIENTIFIC DESIGNS INC. 483
TABLE 699 ALFA SCIENTIFIC DESIGNS INC.: COMPANY OVERVIEW 483
TABLE 700 ALFA SCIENTIFIC DESIGNS INC.: PRODUCTS/SERVICES/
SOLUTIONS OFFERED 483
12.1.6 THERMO FISHER SCIENTIFIC INC. 485
TABLE 701 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 485
FIGURE 56 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 486
TABLE 702 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/
SOLUTIONS OFFERED 486
TABLE 703 THERMO FISHER SCIENTIFIC INC.: PRODUCT DEVELOPMENTS 490
TABLE 704 THERMO FISHER SCIENTIFIC INC.: DEALS 490
12.1.7 DRAGERWERK AG & CO. KGAA 491
TABLE 705 DRAGERWERK AG & CO. KGAA: COMPANY OVERVIEW 491
FIGURE 57 DRAGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023) 492
TABLE 706 DRAGERWERK AG & CO. KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 493
TABLE 707 DRAGERWERK AG & CO. KGAA: PRODUCT LAUNCHES AND APPROVALS 493
12.1.8 LIFELOC TECHNOLOGIES, INC. 494
TABLE 708 LIFELOC TECHNOLOGIES, INC.: COMPANY OVERVIEW 494
FIGURE 58 LIFELOC TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 494
TABLE 709 LIFELOC TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 495
12.1.9 MPD INC. 497
TABLE 710 MPD INC.: COMPANY OVERVIEW 497
TABLE 711 MPD INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 498
12.1.10 OMEGA LABORATORIES, INC. 499
TABLE 712 OMEGA LABORATORIES, INC.: COMPANY OVERVIEW 499
TABLE 713 OMEGA LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 499
TABLE 714 OMEGA LABORATORIES, INC.: SERVICE LAUNCHES 500
TABLE 715 OMEGA LABORATORIES, INC.: DEALS 500
TABLE 716 OMEGA LABORATORIES, INC.: OTHER DEVELOPMENTS 500
12.1.11 PREMIER BIOTECH, INC. 501
TABLE 717 PREMIER BIOTECH, INC.: COMPANY OVERVIEW 501
TABLE 718 PREMIER BIOTECH, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 501
12.1.12 PSYCHEMEDICS CORPORATION 503
TABLE 719 PSYCHEMEDICS CORPORATION: COMPANY OVERVIEW 503
FIGURE 59 PSYCHEMEDICS CORPORATION: COMPANY SNAPSHOT (2023) 503
TABLE 720 PSYCHEMEDICS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 504
12.1.13 F. HOFFMANN-LA ROCHE LTD. 505
TABLE 721 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 505
FIGURE 60 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023) 506
TABLE 722 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 507
12.1.14 SHIMADZU CORPORATION 508
TABLE 723 SHIMADZU CORPORATION: COMPANY OVERVIEW 508
FIGURE 61 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2023) 509
TABLE 724 SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 510
TABLE 725 SHIMADZU CORPORATION: PRODUCT LAUNCHES 510
12.1.15 SIEMENS HEALTHINEERS AG 511
TABLE 726 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 511
FIGURE 62 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 512
TABLE 727 SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 513
TABLE 728 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES 514
TABLE 729 SIEMENS HEALTHINEERS AG: DEALS 514
12.2 OTHER PLAYERS 515
12.2.1 AMERICAN BIO MEDICA CORPORATION 515
TABLE 730 AMERICAN BIO MEDICA CORPORATION: COMPANY OVERVIEW 515
12.2.2 ACM GLOBAL LABORATORIES 516
TABLE 731 ACM GLOBAL LABORATORIES: COMPANY OVERVIEW 516
12.2.3 CAREHEALTH AMERICA CORP. 517
TABLE 732 CAREHEALTH AMERICA CORP.: COMPANY OVERVIEW 517
12.2.4 CLINICAL REFERENCE LABORATORY, INC. 518
TABLE 733 CLINICAL REFERENCE LABORATORY, INC.: COMPANY OVERVIEW 518
12.2.5 INTOXIMETERS 519
TABLE 734 INTOXIMETERS: COMPANY OVERVIEW 519
12.2.6 SCITECK, INC. 520
TABLE 735 SCITECK, INC.: COMPANY OVERVIEW 520
12.2.7 ACCUSOURCEHR, INC. 521
TABLE 736 ACCUSOURCEHR, INC.: COMPANY OVERVIEW 521
12.2.8 CORDANT HEALTH SOLUTIONS 522
TABLE 737 CORDANT HEALTH SOLUTIONS: COMPANY OVERVIEW 522
12.2.9 INTOXALOCK 523
TABLE 738 INTOXALOCK: COMPANY OVERVIEW 523
12.2.10 MILLENNIUM HEALTH 523
TABLE 739 MILLENNIUM HEALTH: COMPANY OVERVIEW 523
12.2.11 ADVACARE PHARMA 524
TABLE 740 ADVACARE PHARMA: COMPANY OVERVIEW 524
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 525
13.1 DISCUSSION GUIDE 525
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS� SUBSCRIPTION PORTAL 530
13.3 CUSTOMIZATION OPTIONS 532
13.4 RELATED REPORTS 532
13.5 AUTHOR DETAILS 533